Literature DB >> 31537534

Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.

Courtenay M Holscher1, Christine E Haugen1, Kyle R Jackson1, Jacqueline M Garonzik Wang1, Madeleine M Waldram1, Sunjae Bae1,2, Jayme E Locke3, Rhiannon D Reed3, Krista L Lentine4, Gaurav Gupta5, Matthew R Weir6, John J Friedewald7, Jennifer Verbesey8, Matthew Cooper8, Dorry L Segev9,2, Allan B Massie1,2.   

Abstract

BACKGROUND AND OBJECTIVES: The risk of hypertension attributable to living kidney donation remains unknown as does the effect of developing postdonation hypertension on subsequent eGFR. We sought to understand the association between living kidney donation, hypertension, and long-term eGFR by comparing donors with a cohort of healthy nondonors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compared 1295 living kidney donors with median 6 years of follow-up with a weighted cohort of 8233 healthy nondonors. We quantified the risk of self-reported hypertension using a parametric survival model. We examined the association of hypertension with yearly change in eGFR using multilevel linear regression and clustering by participant, with an interaction term for race.
RESULTS: Kidney donation was independently associated with a 19% higher risk of hypertension (adjusted hazard ratio, 1.19; 95% confidence interval, 1.01 to 1.41; P=0.04); this association did not vary by race (interaction P=0.60). For white and black nondonors, there was a mean decline in eGFR (-0.4 and -0.3 ml/min per year, respectively) that steepened after incident hypertension (-0.8 and -0.9 ml/min per year, respectively; both P<0.001). For white and black kidney donors, there was a mean increase in eGFR after donation (+0.4 and +0.6 ml/min per year, respectively) that plateaued after incident hypertension (0 and -0.2 ml/min per year, respectively; P=0.07 and P=0.01, respectively, after hypertension).
CONCLUSIONS: Kidney donors are at higher risk of hypertension than similar healthy nondonors, regardless of race. Donors who developed hypertension had a plateau in the usual postdonation increase of eGFR.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  United States; confidence intervals; follow-up studies; glomerular filtration rate; hypertension; kidney; kidney donation; linear models; living donors; self report; tissue and organ harvesting

Year:  2019        PMID: 31537534      PMCID: PMC6777600          DOI: 10.2215/CJN.04020419

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  30 in total

1.  Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests.

Authors:  David Posada; Thomas R Buckley
Journal:  Syst Biol       Date:  2004-10       Impact factor: 15.683

Review 2.  Meta-analysis: risk for hypertension in living kidney donors.

Authors:  Neil Boudville; G V Ramesh Prasad; Greg Knoll; Norman Muirhead; Heather Thiessen-Philbrook; Robert C Yang; M Patricia Rosas-Arellano; Abdulrahman Housawi; Amit X Garg
Journal:  Ann Intern Med       Date:  2006-08-01       Impact factor: 25.391

3.  Uninephrectomy in young age or chronic salt loading causes salt-sensitive hypertension in adult rats.

Authors:  Mattias Carlström; Johan Sällström; Ole Skøtt; Erik Larsson; A Erik G Persson
Journal:  Hypertension       Date:  2007-04-16       Impact factor: 10.190

4.  Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research.

Authors:  Valerie S Harder; Elizabeth A Stuart; James C Anthony
Journal:  Psychol Methods       Date:  2010-09

5.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

6.  Long-term consequences of kidney donation.

Authors:  Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

7.  Medical outcomes in African American live kidney donors: a matched cohort study.

Authors:  M D Doshi; M O Goggins; L Li; A X Garg
Journal:  Am J Transplant       Date:  2012-10-24       Impact factor: 8.086

8.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

9.  Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.

Authors:  S Anjum; A D Muzaale; A B Massie; S Bae; X Luo; M E Grams; K L Lentine; A X Garg; D L Segev
Journal:  Am J Transplant       Date:  2016-07-12       Impact factor: 8.086

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  13 in total

1.  Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.

Authors:  Paolo Strati; Sairah Ahmed; Partow Kebriaei; Loretta J Nastoupil; Catherine M Claussen; Grace Watson; Sandra B Horowitz; Anne Rain T Brown; Bryan Do; Maria A Rodriguez; Ranjit Nair; Elizabeth J Shpall; Michael R Green; Sattva S Neelapu; Jason R Westin
Journal:  Blood Adv       Date:  2020-07-14

Review 2.  Long-term outcomes of laparoscopic versus open donor nephrectomy for kidney transplantation: a meta-analysis.

Authors:  Lingping Wang; Li Zhu; Xubiao Xie; Haifeng Wang; Hui Yin; Chunhua Fang; Helong Dai
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Is Hypertension Following Donor Nephrectomy Cause For Elevated Living Donor Kidney Function Concern?

Authors:  William S Asch
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-19       Impact factor: 8.237

4.  Perceived Susceptibility to Chronic Kidney Disease and Hypertension Self-Management among Black and White Live Kidney Donors.

Authors:  Kevin Gianaris; Grecia B Vargas; Morgan Johnson; Yifan Yu; Elena Wilson; Jamilah A Perkins; Aswad Jackson; L Ebony Boulware; Allan Massie; Macey L Levan; Dorry L Segev; Tanjala S Purnell
Journal:  Ethn Dis       Date:  2022-04-21       Impact factor: 2.006

Review 5.  Assessment of nephron number and single-nephron glomerular filtration rate in a clinical setting.

Authors:  Nobuo Tsuboi; Takaya Sasaki; Yusuke Okabayashi; Kotaro Haruhara; Go Kanzaki; Takashi Yokoo
Journal:  Hypertens Res       Date:  2021-02-01       Impact factor: 3.872

6.  Hypertensive Living Kidney Donor Candidates: What's the Risk?

Authors:  Dag Olav Dahle; Geir Mjøen
Journal:  Kidney Int Rep       Date:  2021-04-03

7.  Outcomes of Hypertensive Kidney Donors Using Current and Past Hypertension Definitions.

Authors:  Hassan N Ibrahim; Sean A Hebert; Dina N Murad; Horacio E Adrogue; Duc T Nguyen; Edward A Graviss; Hana Nguyen; Arthur Matas
Journal:  Kidney Int Rep       Date:  2021-03-03

8.  Hypertension, cardiovascular disease and cause of death in Danish living kidney donors: matched cohort study.

Authors:  Mavish Chaudry; Gunnar Hilmar Gislason; Emil Loldrup Fosbøl; Lars Køber; Thomas Alexander Gerds; Christian Torp-Pedersen
Journal:  BMJ Open       Date:  2020-11-09       Impact factor: 2.692

9.  The Salutary Blood Pressure of a Solitary Kidney.

Authors:  Dag Olav Dahle; Geir Mjoen
Journal:  Am J Hypertens       Date:  2020-03-13       Impact factor: 2.689

Review 10.  Prevalence, Mechanisms, Treatment, and Complications of Hypertension Postliving Kidney Donation.

Authors:  Stuart Deoraj; Dimitrios Anestis Moutzouris; Maria Irene Bellini
Journal:  Biomed Res Int       Date:  2021-02-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.